Resource Center
Articles
-
Prevalence of metabolic syndrome in the Canadian adult population.
Riediger ND, Clara I. CMAJ. 2011;183:E1127-134.
-
Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies.
Loke YK, Kwok CS, Singh S. BMJ. 2011;342:d1309.
-
Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins.
Ansar S, Koska J, Reaven PD. Cardiovasc Diabetol. 2011;10:61.
-
Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol--United States, 1999-2002 and 2005-200.
Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2011;60:109-114.
-
Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies.
Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA. BMJ. 2011;342:d636. doi: 10.1136/bmj.d636.
-
Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis.
Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. BMJ. 2011;342:d671. doi: 10.1136/bmj.d671.
-
Medical clinics versus usual care for patients with both diabetes and hypertension: a randomized trial
Edelman D, Fredrickson SK, Melnyk SD, et al. Ann Intern Med. 2010;152:689-696.
-
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration, Sarwar N, Sandhu MS, et al. Lancet. 2010;375:1634-1639.
-
Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality
Nissen SE, Wolski K. Arch Intern Med. 2010; DOI:10.1001/archinte.2010.207.
-
Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone
Graham DJ, Ouellet-Hellstrom R, MaCurdy TE, et al. JAMA. 2010; DOI:10.1001/jama.jama.2010.920.
-
Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome
Carr DB, Utzschneider KM, Hull RL, et al. Diabetes. 2004;53:2087-2093.
